Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Serge Jabbour from Thomas Jefferson University in Philadelphia, Pennsylvania, and colleagues aimed to describe the clinical course in terms of body weight, glycemic outcomes, and adverse events during the first 12 weeks following a switch from GLP-1 receptor agonists directly to tirzepatide 5 mg in a prospective study
doi: 10.1111/nyas.13531
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock
The global kidney patient trials network and the captivate platform clinical trial design: a trial protocol
Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe Islands
US$ 20.16
US$ 25.90
US$ 25.32
US$ 23.85
